These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 7601299)
1. High efficacy and low frequency of headache recurrence after oral sumatriptan. The Oral Sumatriptan Italian Study Group. Pini LA; Sternieri E; Fabbri L; Zerbini O; Bamfi F J Int Med Res; 1995; 23(2):96-105. PubMed ID: 7601299 [TBL] [Abstract][Full Text] [Related]
2. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study. Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159 [TBL] [Abstract][Full Text] [Related]
3. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group. Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168 [TBL] [Abstract][Full Text] [Related]
4. Oral sumatriptan: effect of a second dose, and incidence and treatment of headache recurrences. Ferrari MD; James MH; Bates D; Pilgrim A; Ashford E; Anderson BA; Nappi G Cephalalgia; 1994 Oct; 14(5):330-8. PubMed ID: 7828190 [TBL] [Abstract][Full Text] [Related]
5. A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group. Savani N; Brautaset NJ; Reunanen M; Szirmai I; Ashford EA; Hassani H; Saiers J Int J Clin Pract Suppl; 1999 Aug; 105():7-15. PubMed ID: 10692717 [TBL] [Abstract][Full Text] [Related]
6. Subcutaneous sumatriptan for treatment of acute migraine in patients admitted to the emergency department: a multicenter study. Akpunonu BE; Mutgi AB; Federman DJ; Volinsky FG; Brickman K; Davis RL; Gilbert C; Asgharnejad M Ann Emerg Med; 1995 Apr; 25(4):464-9. PubMed ID: 7710149 [TBL] [Abstract][Full Text] [Related]
7. Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Plosker GL; McTavish D Drugs; 1994 Apr; 47(4):622-51. PubMed ID: 7516861 [TBL] [Abstract][Full Text] [Related]
9. Oral sumatriptan in the acute treatment of migraine and migraine recurrence in general practice. Scott RJ; Aitchison WR; Barker PR; McLaren GI QJM; 1996 Aug; 89(8):613-22. PubMed ID: 8935482 [TBL] [Abstract][Full Text] [Related]
10. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults. Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463 [TBL] [Abstract][Full Text] [Related]
11. Oral sumatriptan for the long-term treatment of migraine: clinical findings. Rederich G; Rapoport A; Cutler N; Hazelrigg R; Jamerson B Neurology; 1995 Aug; 45(8 Suppl 7):S15-20. PubMed ID: 7644080 [TBL] [Abstract][Full Text] [Related]
12. Oral sumatriptan is effective and well tolerated for the acute treatment of migraine: results of a multicenter study. Sargent J; Kirchner JR; Davis R; Kirkhart B Neurology; 1995 Aug; 45(8 Suppl 7):S10-4. PubMed ID: 7644079 [TBL] [Abstract][Full Text] [Related]
13. Oral sumatriptan in the treatment of recurrent headache. Cady RK; Rubino J; Crummett D; Littlejohn TW Arch Fam Med; 1994 Sep; 3(9):766-72. PubMed ID: 7987510 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of sumatriptan 50 mg in patients not responding to standard care, in the treatment of mild to moderate migraine. The Sumatriptan 50 mg Italian Study Group. Pini LA; Fabbri L; Cavazzuti L Int J Clin Pharmacol Res; 1999; 19(2):57-64. PubMed ID: 10669900 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, multicentre study. Sandrini G; Cerbo R; Del Bene E; Ferrari A; Genco S; Grazioli I; Martelletti P; Nappi G; Pinessi L; Sarchielli P; Tamburro P; Uslenghi C; Zanchin G Int J Clin Pract; 2007 Aug; 61(8):1256-69. PubMed ID: 17627707 [TBL] [Abstract][Full Text] [Related]
16. Oral sumatriptan compared with placebo in the acute treatment of migraine. Nappi G; Sicuteri F; Byrne M; Roncolato M; Zerbini O J Neurol; 1994 Jan; 241(3):138-44. PubMed ID: 8164015 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study. Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050 [TBL] [Abstract][Full Text] [Related]
18. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets. Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814 [TBL] [Abstract][Full Text] [Related]
19. Oral sumatriptan for the acute treatment of migraine: evaluation of three dosage strengths. Cutler N; Mushet GR; Davis R; Clements B; Whitcher L Neurology; 1995 Aug; 45(8 Suppl 7):S5-9. PubMed ID: 7644082 [TBL] [Abstract][Full Text] [Related]
20. Sumatriptan and naproxen sodium for the acute treatment of migraine. Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]